O	0	4	ICAM	ICAM	NN	B-NP
O	4	5	-	-	HYPH	B-NP
O	5	6	3	3	CD	I-NP
O	7	15	enhances	enhance	VBZ	B-VP
O	16	19	the	the	DT	B-NP
O	20	29	migratory	migratory	JJ	I-NP
O	30	33	and	and	CC	I-NP
O	34	42	invasive	invasive	JJ	I-NP
O	43	52	potential	potential	NN	I-NP
O	53	55	of	of	IN	B-PP
O	56	61	human	human	JJ	B-NP
B-Cell	62	65	non	non	AFX	I-NP
I-Cell	65	66	-	-	HYPH	I-NP
I-Cell	66	71	small	small	JJ	B-NP
I-Cell	72	76	cell	cell	NN	I-NP
I-Cell	77	81	lung	lung	NN	I-NP
I-Cell	82	88	cancer	cancer	NN	I-NP
I-Cell	89	94	cells	cell	NNS	I-NP
O	95	97	by	by	IN	B-PP
O	98	106	inducing	induce	VBG	B-VP
O	107	110	MMP	MMP	NN	B-NP
O	110	111	-	-	HYPH	B-NP
O	111	112	2	2	CD	I-NP
O	113	116	and	and	CC	I-NP
O	117	120	MMP	MMP	NN	I-NP
O	120	121	-	-	HYPH	O
O	121	122	9	9	CD	B-NP
O	123	126	via	via	IN	B-PP
O	127	130	Akt	Akt	NN	B-NP
O	131	134	and	and	CC	I-NP
O	135	139	CREB	CREB	NN	I-NP
O	139	140	.	.	.	O

O	142	144	We	We	PRP	B-NP
O	145	149	have	have	VBP	B-VP
O	150	160	previously	previously	RB	I-VP
O	161	169	reported	report	VBN	I-VP
O	170	174	that	that	IN	B-SBAR
O	175	188	intercellular	intercellular	JJ	B-NP
O	189	197	adhesion	adhesion	NN	I-NP
O	198	206	molecule	molecule	NN	I-NP
O	206	207	-	-	HYPH	B-NP
O	207	208	3	3	CD	I-NP
O	209	210	(	(	(	O
O	210	214	ICAM	ICAM	NN	B-NP
O	214	215	-	-	HYPH	B-ADJP
O	215	216	3	3	LS	B-LST
O	216	217	)	)	)	O
O	218	220	is	be	VBZ	B-VP
O	221	231	associated	associate	VBN	I-VP
O	232	236	with	with	IN	B-PP
O	237	239	an	an	DT	B-NP
O	240	248	increase	increase	NN	I-NP
O	249	251	of	of	IN	B-PP
B-Cell	252	260	cellular	cellular	JJ	B-NP
O	261	266	radio	radio	AFX	I-NP
O	266	267	-	-	HYPH	I-NP
O	267	277	resistance	resistance	NN	I-NP
O	278	281	and	and	CC	I-NP
B-Cell	282	288	cancer	cancer	NN	I-NP
I-Cell	289	293	cell	cell	NN	I-NP
O	294	307	proliferation	proliferation	NN	I-NP
O	307	308	.	.	.	O

O	309	311	In	In	IN	B-PP
O	312	316	this	this	DT	B-NP
O	317	322	study	study	NN	I-NP
O	322	323	,	,	,	O
O	324	326	we	we	PRP	B-NP
O	327	339	hypothesized	hypothesize	VBD	B-VP
O	340	344	that	that	IN	B-SBAR
O	345	349	ICAM	ICAM	NN	B-NP
O	349	350	-	-	HYPH	B-NP
O	350	351	3	3	CD	I-NP
O	352	355	has	have	VBZ	B-VP
O	356	358	an	an	DT	B-NP
O	359	369	additional	additional	JJ	I-NP
O	370	376	effect	effect	NN	I-NP
O	377	379	on	on	IN	B-PP
B-Cell	380	386	cancer	cancer	NN	B-NP
I-Cell	387	391	cell	cell	NN	I-NP
O	392	401	migration	migration	NN	I-NP
O	402	405	and	and	CC	O
O	406	414	invasion	invasion	NN	B-NP
O	415	422	because	because	IN	B-SBAR
O	423	432	molecules	molecule	NNS	B-NP
O	433	440	induced	induce	VBN	B-VP
O	441	443	by	by	IN	B-PP
O	444	448	ICAM	ICAM	NN	B-NP
O	448	449	-	-	HYPH	B-NP
O	449	450	3	3	CD	I-NP
O	451	454	are	be	VBP	B-VP
O	455	460	known	know	VBN	I-VP
O	461	463	as	as	IN	B-PP
O	464	474	regulators	regulator	NNS	B-NP
O	475	477	of	of	IN	B-PP
B-Cell	478	482	cell	cell	NN	B-NP
O	483	492	migration	migration	NN	I-NP
O	493	496	and	and	CC	I-NP
O	497	505	invasion	invasion	NN	I-NP
O	505	506	.	.	.	O

O	507	509	To	To	TO	B-VP
O	510	517	examine	examine	VB	I-VP
O	518	522	this	this	DT	B-NP
O	523	533	hypothesis	hypothesis	NN	I-NP
O	533	534	,	,	,	O
O	535	537	we	we	PRP	B-NP
O	538	542	used	use	VBD	B-VP
B-Cell	543	546	NCI	NCI	NN	B-NP
I-Cell	546	547	-	-	HYPH	B-NP
I-Cell	547	552	H1299	H1299	NN	I-NP
I-Cell	553	556	non	non	AFX	O
I-Cell	556	557	-	-	HYPH	B-VP
I-Cell	557	562	small	small	JJ	B-NP
I-Cell	563	567	cell	cell	NN	I-NP
I-Cell	568	572	lung	lung	NN	I-NP
I-Cell	573	579	cancer	cancer	NN	I-NP
I-Cell	580	581	(	(	(	O
I-Cell	581	586	NSCLC	NSCLC	NN	B-NP
I-Cell	586	587	)	)	)	O
I-Cell	588	592	cell	cell	NN	B-NP
I-Cell	593	597	line	line	NN	I-NP
O	598	599	(	(	(	O
B-Cell	599	602	p53	p53	NN	B-NP
I-Cell	603	606	and	and	CC	O
I-Cell	607	611	PTEN	PTEN	NN	B-NP
I-Cell	612	616	null	null	JJ	I-NP
I-Cell	617	621	cell	cell	NN	I-NP
O	621	622	)	)	)	O
O	623	626	and	and	CC	O
O	627	638	constructed	construct	VBN	B-VP
O	639	641	an	an	DT	B-NP
O	642	646	ICAM	ICAM	NN	I-NP
O	646	647	-	-	HYPH	B-NP
O	647	648	3	3	CD	I-NP
O	648	649	-	-	HYPH	B-ADJP
O	649	653	over	over	AFX	B-PP
O	653	654	-	-	HYPH	B-NP
O	654	664	expressing	express	VBG	B-VP
O	665	671	stable	stable	JJ	B-NP
B-Cell	672	684	transfectant	transfectant	NN	I-NP
O	684	685	,	,	,	O
O	686	691	which	which	WDT	B-NP
O	692	701	exhibited	exhibit	VBD	B-VP
O	702	711	increased	increase	VBN	B-NP
B-Cell	712	716	cell	cell	NN	I-NP
O	717	726	migration	migration	NN	I-NP
O	727	730	and	and	CC	I-NP
O	731	739	invasion	invasion	NN	I-NP
O	739	740	.	.	.	O

O	741	744	The	The	DT	B-NP
O	745	754	increased	increase	VBN	I-NP
O	755	764	migration	migration	NN	I-NP
O	765	768	and	and	CC	I-NP
O	769	777	invasion	invasion	NN	I-NP
O	778	786	resulted	result	VBD	B-VP
O	787	791	from	from	IN	B-PP
O	792	794	up	up	RB	B-ADVP
O	794	795	-	-	HYPH	O
O	795	805	regulation	regulation	NN	B-NP
O	806	808	of	of	IN	B-PP
O	809	819	expression	expression	NN	B-NP
O	820	823	and	and	CC	O
O	824	834	activities	activity	NNS	B-NP
O	835	837	of	of	IN	B-PP
O	838	841	MMP	MMP	NN	B-NP
O	841	842	-	-	HYPH	B-NP
O	842	843	2	2	CD	I-NP
O	844	847	and	and	CC	O
O	848	851	MMP	MMP	NN	B-NP
O	851	852	-	-	:	O
O	852	853	9	9	CD	B-NP
O	853	854	.	.	.	O

O	855	859	ICAM	ICAM	NN	B-NP
O	859	860	-	-	HYPH	I-NP
O	860	861	3	3	CD	I-NP
O	862	866	also	also	RB	B-ADVP
O	867	876	increased	increase	VBD	B-VP
O	877	880	Akt	Akt	NN	B-NP
O	881	896	phosphorylation	phosphorylation	NN	I-NP
O	896	897	,	,	,	O
O	898	903	which	which	WDT	B-NP
O	904	910	caused	cause	VBD	B-VP
O	911	913	an	an	DT	B-NP
O	914	922	increase	increase	NN	I-NP
O	923	925	in	in	IN	B-PP
B-Cell	926	934	cellular	cellular	JJ	B-NP
O	935	944	migration	migration	NN	I-NP
O	944	945	/	/	SYM	B-NP
O	945	953	invasion	invasion	NN	I-NP
O	954	957	and	and	CC	I-NP
O	958	961	MMP	MMP	NN	I-NP
O	962	972	activities	activity	NNS	I-NP
O	972	973	.	.	.	O

O	974	982	Activity	Activity	NN	B-NP
O	983	985	of	of	IN	B-PP
O	986	993	several	several	JJ	B-NP
O	994	1009	transcriptional	transcriptional	JJ	I-NP
O	1010	1017	factors	factor	NNS	I-NP
O	1018	1025	located	located	JJ	B-ADJP
O	1026	1036	downstream	downstream	RB	B-ADVP
O	1037	1039	in	in	IN	B-PP
O	1040	1043	the	the	DT	B-NP
O	1044	1047	Akt	Akt	NN	I-NP
O	1048	1055	pathway	pathway	NN	I-NP
O	1056	1059	was	be	VBD	B-VP
O	1060	1064	also	also	RB	I-VP
O	1065	1071	tested	test	VBN	I-VP
O	1071	1072	,	,	,	O
O	1073	1076	and	and	CC	O
O	1077	1089	constitutive	constitutive	JJ	B-NP
O	1090	1100	activation	activation	NN	I-NP
O	1101	1103	of	of	IN	B-PP
O	1104	1113	adenosine	adenosine	NN	B-NP
O	1114	1115	3	3	CD	I-NP
O	1115	1116	'	'	SYM	B-NP
O	1116	1117	,	,	,	O
O	1118	1119	5	5	CD	B-NP
O	1119	1120	'	'	SYM	I-NP
O	1120	1121	-	-	HYPH	I-NP
O	1121	1134	monophosphate	monophosphate	NN	I-NP
O	1135	1143	response	response	NN	I-NP
O	1144	1151	element	element	NN	I-NP
O	1151	1152	-	-	HYPH	O
O	1152	1159	binding	bind	VBG	B-VP
O	1160	1167	protein	protein	NN	B-NP
O	1168	1169	(	(	(	O
O	1169	1173	CREB	CREB	NN	B-NP
O	1173	1174	)	)	)	O
O	1175	1177	by	by	IN	B-PP
O	1178	1182	ICAM	ICAM	NN	B-NP
O	1182	1183	-	-	HYPH	B-NP
O	1183	1184	3	3	CD	I-NP
O	1185	1188	was	be	VBD	B-VP
O	1189	1197	detected	detect	VBN	I-VP
O	1197	1198	.	.	.	O

O	1199	1207	Blockage	Blockage	NN	B-NP
O	1208	1210	of	of	IN	B-PP
O	1211	1214	the	the	DT	B-NP
O	1215	1218	Akt	Akt	NN	I-NP
O	1219	1226	pathway	pathway	NN	I-NP
O	1227	1237	attenuated	attenuate	VBD	B-VP
O	1238	1242	CREB	CREB	NN	B-NP
O	1243	1253	activation	activation	NN	I-NP
O	1253	1254	,	,	,	O
O	1255	1258	and	and	CC	O
O	1259	1260	a	a	DT	B-NP
O	1261	1269	decrease	decrease	NN	I-NP
O	1270	1272	in	in	IN	B-PP
O	1273	1277	CREB	CREB	NN	B-NP
O	1278	1288	expression	expression	NN	I-NP
O	1289	1296	reduced	reduce	VBD	B-VP
B-Cell	1297	1305	cellular	cellular	JJ	B-NP
O	1306	1315	migration	migration	NN	I-NP
O	1315	1316	/	/	SYM	B-NP
O	1316	1324	invasion	invasion	NN	I-NP
O	1325	1328	and	and	CC	I-NP
O	1329	1337	activity	activity	NN	I-NP
O	1338	1340	of	of	IN	B-PP
O	1341	1345	MMPs	MMP	NNS	B-NP
O	1345	1346	.	.	.	O

O	1347	1351	This	This	DT	B-NP
O	1352	1358	result	result	NN	I-NP
O	1359	1368	indicates	indicate	VBZ	B-VP
O	1369	1373	that	that	IN	B-SBAR
O	1374	1378	CREB	CREB	NN	B-NP
O	1379	1388	functions	function	NNS	I-NP
O	1389	1391	in	in	IN	B-PP
O	1392	1395	the	the	DT	B-NP
O	1396	1405	signaling	signaling	NN	I-NP
O	1406	1413	pathway	pathway	NN	I-NP
O	1414	1421	between	between	IN	B-PP
O	1422	1425	Akt	Akt	NN	B-NP
O	1426	1429	and	and	CC	I-NP
O	1430	1433	MMP	MMP	NN	I-NP
O	1433	1434	.	.	.	O

O	1435	1437	We	We	PRP	B-NP
O	1438	1442	also	also	RB	B-ADVP
O	1443	1449	showed	show	VBD	B-VP
O	1450	1454	ICAM	ICAM	NN	B-NP
O	1454	1455	-	-	HYPH	B-NP
O	1455	1456	3	3	CD	I-NP
O	1456	1457	-	-	HYPH	I-NP
O	1457	1464	induced	induce	VBN	I-NP
B-Cell	1465	1469	cell	cell	NN	I-NP
O	1470	1479	migration	migration	NN	I-NP
O	1480	1483	and	and	CC	I-NP
O	1484	1492	invasion	invasion	NN	I-NP
O	1493	1495	in	in	IN	B-PP
B-Cell	1496	1499	NCI	NCI	NN	B-NP
I-Cell	1499	1500	-	-	HYPH	B-NP
I-Cell	1500	1504	H460	H460	NN	I-NP
I-Cell	1505	1510	NSCLC	NSCLC	NN	I-NP
I-Cell	1511	1516	cells	cell	NNS	I-NP
O	1517	1518	(	(	(	O
B-Cell	1518	1522	wild	wild	JJ	B-NP
I-Cell	1522	1523	-	-	HYPH	I-NP
I-Cell	1523	1527	type	type	NN	I-NP
I-Cell	1528	1531	p53	p53	NN	I-NP
I-Cell	1532	1535	and	and	CC	O
I-Cell	1536	1540	PTEN	PTEN	NN	B-NP
I-Cell	1541	1545	cell	cell	NN	I-NP
O	1545	1546	)	)	)	O
O	1547	1554	through	through	IN	B-PP
O	1555	1558	the	the	DT	B-NP
O	1559	1563	same	same	JJ	I-NP
O	1564	1573	signaling	signaling	NN	I-NP
O	1574	1581	pathway	pathway	NN	I-NP
O	1581	1582	.	.	.	O

O	1583	1588	Taken	Take	VBN	B-VP
O	1589	1597	together	together	RB	B-ADVP
O	1597	1598	,	,	,	O
O	1599	1602	our	our	PRP$	B-NP
O	1603	1611	findings	finding	NNS	I-NP
O	1612	1619	suggest	suggest	VBP	B-VP
O	1620	1624	that	that	IN	B-SBAR
O	1625	1629	ICAM	ICAM	NN	B-NP
O	1629	1630	-	-	HYPH	B-NP
O	1630	1631	3	3	CD	I-NP
O	1632	1642	stimulates	stimulate	VBZ	B-VP
B-Cell	1643	1649	cancer	cancer	NN	B-NP
I-Cell	1650	1654	cell	cell	NN	I-NP
O	1655	1664	migration	migration	NN	I-NP
O	1664	1665	/	/	SYM	B-NP
O	1665	1673	invasion	invasion	NN	I-NP
O	1674	1677	via	via	IN	B-PP
O	1678	1682	ICAM	ICAM	NN	B-NP
O	1682	1683	-	-	HYPH	B-NP
O	1683	1684	3	3	CD	I-NP
O	1684	1685	/	/	SYM	I-NP
O	1685	1688	Akt	Akt	NN	I-NP
O	1688	1689	/	/	SYM	I-NP
O	1689	1693	CREB	CREB	NN	I-NP
O	1693	1694	/	/	SYM	B-NP
O	1694	1697	MMP	MMP	NN	I-NP
O	1698	1705	pathway	pathway	NN	I-NP
O	1706	1716	regardless	regardless	RB	B-ADVP
O	1717	1719	of	of	IN	B-PP
O	1720	1723	p53	p53	NN	B-NP
O	1724	1727	and	and	CC	I-NP
O	1728	1732	PTEN	PTEN	NN	I-NP
O	1733	1739	status	status	NN	I-NP
O	1739	1740	,	,	,	O
O	1741	1744	and	and	CC	O
O	1745	1749	this	this	DT	B-NP
O	1750	1758	reflects	reflect	VBZ	B-VP
O	1759	1762	the	the	DT	B-NP
O	1763	1774	possibility	possibility	NN	I-NP
O	1775	1779	that	that	IN	B-SBAR
O	1780	1784	ICAM	ICAM	NN	B-NP
O	1784	1785	-	-	HYPH	B-NP
O	1785	1786	3	3	CD	I-NP
O	1787	1792	could	could	MD	B-VP
O	1793	1795	be	be	VB	I-VP
O	1796	1806	considered	consider	VBN	I-VP
O	1807	1809	as	as	IN	B-PP
O	1810	1811	a	a	DT	B-NP
O	1812	1821	candidate	candidate	NN	I-NP
O	1822	1825	for	for	IN	B-PP
O	1826	1830	anti	anti	AFX	B-NP
O	1830	1831	-	-	HYPH	I-NP
B-Cancer	1831	1837	cancer	cancer	NN	I-NP
O	1838	1842	drug	drug	NN	I-NP
O	1843	1854	development	development	NN	I-NP
O	1855	1858	and	and	CC	B-PP
O	1859	1861	as	as	IN	B-PP
O	1862	1863	a	a	DT	B-NP
B-Cancer	1864	1870	cancer	cancer	NN	I-NP
O	1871	1881	diagnostic	diagnostic	JJ	I-NP
O	1882	1888	marker	marker	NN	I-NP
O	1888	1889	.	.	.	O

